New guidelines aim to reduce the prevalence of methicillin-resistant Staphylococcus aureus (MRSA), improve patient safety and prioritize current prevention efforts underway in hospitals. This drug resistant bacterium is a common source of patient morbidity and mortality in U.S. hospitals, causing nearly twice the number of deaths, significantly longer hospital stays and higher hospital costs than other forms of the bacteria.
The strategies were published in the July issue of Infection Control and Hospital Epidemiology and produced in a collaborative effort led by the Society for Healthcare Epidemiology of America, the Infectious Diseases Society of America, the American Hospital Association, the Association for Professionals in Infection Control and Epidemiology, and The Joint Commission.
"Many hospitals have made inroads in preventing healthcare-associated MRSA through essential prevention strategies, but some hospitals need additional intervention," said David Calfee, MD, MS, co-lead author of the guidelines with Cassandra Salgado, MD, MS. "This guidance provides a roadmap for prioritizing and implementing strategies."
Key highlights from the guidelines include:
"There is no "one-size-fits-all" approach to improving practices. Local contextual factors matter when implementing strategies," said Edward Septimus, MD, an author of the commentary, Approaches for Prevention Healthcare-Associated Infections: Go Long or Go Wide, also published in the July issue.
The new practice recommendations are a part of Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates, a series of articles to be published over several months sharing evidence-based strategies to help healthcare professionals effectively control and prevent the spread of healthcare-associated infections (HAIs). The 2014 release revises the initial 2008 Compendium publication.
Cite This Page: